Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hidden toll of cancer treatment: muscle loss and brain fog persist

NCT ID NCT05800535

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 100 cancer survivors aged 18–74 to see how common muscle loss (sarcopenia) and cognitive problems ('chemo brain') are after treatment. Participants undergo physical and mental assessments. The goal is to better understand these long-term side effects and guide patients to helpful resources like exercise programs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help identify how common muscle loss and 'chemo brain' are in cancer survivors, leading to better support programs.
What could go wrong
This is an observational study, not a treatment trial. It only measures problems without testing any new therapy, so it won't directly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer cancer Chemotherapy-Related Cognitive Impairment colon carcinoma hematopoietic and lymphoid cell neoplasm kidney cancer lung cancer malignant pancreatic neoplasm melanoma neoplasm ovarian cancer Sarcopenia testicular cancer urinary bladder carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER SARCOPENIA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service de Rhumatologie, Hospices Civils de Lyon, Groupement Hospitalier Lyon Sud

    RECRUITING

    Pierre-Bénite, 69310, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.